Former Unicorn Growth Hustler Vidyanand Kumar Launches Vitachemie Pharmaceuticals to Revolutionize Affordable Healthcare
Leveraging seven years of expansion expertise from Swiggy and Oyo, CEO Vidyanand Kumar pivots to the pharmaceutical sector to bridge the gap in quality and cost-effective medicine across India.

​DATELINE: NAWADA, BIHAR — FEBRUARY 19, 2026

​Vidyanand Kumar, a seasoned business leader with a distinguished seven-year track record of scaling India's most prominent unicorns, including Swiggy and Oyo, has officially announced the launch of his latest venture: Vitachemie Pharmaceuticals Private Limited. As Co-founder and CEO, Kumar is pivoting from the high-velocity tech-operations sector to the pharmaceutical industry with a clear, singular mission: to bridge the gap between high-quality medicine and affordability for the Indian masses. Registered under CIN U47721BR2025PTC073935, Vitachemie Pharmaceuticals enters the market at a critical juncture where the demand for reliable, cost-effective healthcare solutions is at an all-time high.

​From Unicorn Logistics to Life-Saving Healthcare

Having played a pivotal role in the hyper-growth phases of Swiggy and Oyo, Vidyanand Kumar brings a unique "tech-first" efficiency and a deep understanding of Indian consumer logistics to the healthcare space. His experience in managing complex, large-scale delivery networks and property expansions provides Vitachemie with a competitive edge in supply chain optimization—a critical factor in reducing the end-cost of medications for patients.

​"My journey with India's tech giants taught me how to scale solutions that touch millions of lives daily," said Vidyanand Kumar, CEO of Vitachemie Pharmaceuticals. "The pharmaceutical industry is ripe for a similar transformation. Quality medicine should not be a luxury reserved for the few; it is a fundamental right. At Vitachemie, we are applying the same dynamic growth mindset to healthcare—building a lean, quality-driven engine to ensure that world-class healthcare is accessible to every corner of the country, from metro cities to the most underserved rural villages."

​A Focus on Therapeutic Excellence and Quality

Vitachemie Pharmaceuticals is dedicated to the manufacturing and distribution of products that meet stringent WHO-GMP (World Health Organization - Good Manufacturing Practices) standards. The company's current portfolio is designed to address prevalent health challenges in the Indian population through precise formulations and high-bioavailability ingredients.
Website: www.vitachemiepharmaceuticals.com
Email: [email protected]